Technical / White Paper

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Published

Format: PDF file | Document type: Technical / White Paper

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Related categories: Contract sales & marketing, Drug delivery, formulation, Phase III-IV

Download PDF Now!

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical. Outsourcing of drug product manufacturing to a contract manufacturing organization with experience in handling different products in multiproduct facilities can be an option. However, the experience and expertise of the CMO is crucial to avoid the risk of cross-contamination of the drug product, as failures or weaknesses in this process can pose risk to the end-user.

Related resources from Baxter BioPharma Solutions

Show more

Supplier info centre